• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Neutrophil gene expression in COVID-19 patients with acute respiratory distress syndrome

tetano

Editor, Senior Moderator
Front Immunol


. 2025 Nov 6:16:1620745.
doi: 10.3389/fimmu.2025.1620745. eCollection 2025. Neutrophil gene expression in COVID-19 patients with acute respiratory distress syndrome

Hiroshi Ito[SUP] #[/SUP][SUP] 1 [/SUP], Masakazu Ishikawa[SUP] #[/SUP][SUP] 2 3 [/SUP], Jumpei Yoshimura[SUP] #[/SUP][SUP] 1 [/SUP], Yuchen Liu[SUP] 2 [/SUP], Shuhei Sakakibara[SUP] 4 [/SUP], Fuminori Sugihara[SUP] 5 [/SUP], Hisatake Matsumoto[SUP] 1 [/SUP], Haruhiko Hirata[SUP] 6 [/SUP], Hiroshi Ogura[SUP] 1 [/SUP], Jun Oda[SUP] 1 [/SUP], Daisuke Okuzaki[SUP] 2 3 7 8 [/SUP]



Affiliations
Abstract

Background: Although an increase in neutrophil count has been observed in patients with coronavirus disease 2019 (COVID-19), the relationship between the systemic neutrophil transcriptome and clinical course of COVID-19 remains unclear. Hence, we examined the relationship between the clinical course and RNA sequencing analysis results in COVID-19 patients.
Methods: Peripheral blood samples were obtained from 28 patients with COVID-19-associated ARDS and 16 healthy controls. Bulk RNA sequencing was performed, and clustering analysis was used to explore relationships between gene expression and clinical characteristics. In a separate cohort, neutrophils were isolated from the peripheral blood of five COVID-19 patients with ARDS for single-cell RNA sequencing to further characterize the neutrophil subpopulations.
Results: In bulk RNA sequencing analysis, COVID-19 patients with ARDS had elevated gene expression associated with neutrophils compared with healthy controls.Clustering analysis revealed no differences in the clinical characteristics of COVID-19 patients with ARDS. In the single-cell RNA sequencing analysis, clustering analysis showed that the patients were divided into two groups: those who could be weaned from the ventilator within 28 days and those who could not be weaned.
Conclusion: These findings indicate that differences in neutrophil gene expression may have important clinical implications. This study may support the exploratory identification of genomic factors, such as neutrophil gene expression, that are relevant to clinical parameters.

Keywords: acute respiratory distress syndrome; coronavirus disease 2019 (COVID-19); gene expression; neutrophil; single-cell RNA sequencing.

 
Back
Top Bottom